Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Equity Ratio (2016 - 2025)

Mimedx (MDXG) has disclosed Equity Ratio for 15 consecutive years, with 0.75 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 2.32% to 0.75 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.75 through Dec 2025, up 2.32% year-over-year, with the annual reading at 0.75 for FY2025, 2.32% up from the prior year.
  • Equity Ratio hit 0.75 in Q4 2025 for Mimedx, roughly flat from 0.75 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.75 in Q1 2025 to a low of 0.11 in Q3 2022.
  • Historically, Equity Ratio has averaged 0.29 across 5 years, with a median of 0.0 in 2021.
  • Biggest five-year swings in Equity Ratio: tumbled 24147.84% in 2022 and later soared 10447.82% in 2024.
  • Year by year, Equity Ratio stood at 0.0 in 2021, then crashed by 24147.84% to 0.1 in 2022, then surged by 668.98% to 0.6 in 2023, then rose by 22.56% to 0.73 in 2024, then increased by 2.32% to 0.75 in 2025.
  • Business Quant data shows Equity Ratio for MDXG at 0.75 in Q4 2025, 0.75 in Q3 2025, and 0.74 in Q2 2025.